Viokace

Pancrelipase Tablets: Pancreatic Enzyme Replacement Therapy (PERT)

Pancrelipase is an Enzyme Preparation used to manage digestive disorders. While originally approved for human use (under the brand name Viokace), it is widely utilised in veterinary medicine on an extra-label basis for dogs and cats. This medication provides a concentrated mixture of three essential enzymes—lipase, protease, and amylase—which are naturally produced by the pancreas to break down fats, proteins, and carbohydrates. It is the primary treatment for pets whose bodies can no longer produce these enzymes naturally.

Key Information

• Active Ingredients: Lipase (20,880 USP Units), Protease (112,500 USP Units), and Amylase (113,400 USP Units).

• Approved Species (Original Licensing): Human.

• Common Veterinary Species: Dog and Cat (used extra-label).

• Uses: Management of Exocrine Pancreatic Insufficiency (EPI) and maldigestion syndrome.

• Form: Tan, oval, non-scored tablet.

• Route of Administration: Oral.

Prescription Required

Pancrelipase is a prescription-only medication. A valid prescription from a licensed veterinarian is required for purchase. Professional veterinary oversight is essential to determine the correct dosage based on your pet’s weight and the severity of their condition. Because these enzymes can be irritating to the tissues of the mouth and oesophagus, your veterinarian will provide specific instructions on how to safely administer the tablets to ensure they reach the stomach without causing local irritation.